abstract |
Aβ2 inhibitory biphenyl heterocycles for use in the treatment of diabetes and related diseases, especially type II diabetes, have been reported using aP2 inhibitor or such aP2 inhibitor and another anti-diabetic agent such as metformin, glyburide, troglitazone and / or insulin. |